India court grants Herceptin injunction
February 10, 2014Research and Development, Sales and Marketing Biocon, Herceptin, India, Mylan, Roche
Roche has been granted an injunction by a court in India to prevent generic manufacturers of its ageing breast cancer …
Doctors and developers partner for X-ray app
February 10, 2014Medical Communications, Sales and Marketing app, digital, experior, lynch, xray
Doctors in Northern Ireland have Belfast have teamed up with IT specialists to develop a new smartphone app that can …
In search of the tipping point
February 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing abbey, goldman, marketing, tipping point
The germ of an idea, a very good idea. What if the idea could, like a germ, be a contagious …
Pharmarama International names chief executive
February 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmarama, whittley
Medicines wholesaler and trials supplier Pharmarama International has hired Nadia Whittley to be its new chief executive. Prior to joining …
AbbVie expands into Singapore
February 10, 2014Manufacturing and Production, Sales and Marketing AbbVie, Abbott, Asia, Cancer, Singapore, oncology
AbbVie is expanding its manufacturing operation into Asia for the first time with a $320 million investment in a new …
Merck: ‘2014 revenues will be down’
February 7, 2014Sales and Marketing Frazier, Merck, Simponi, Singulair, isentress, q4, results
Merck is the latest pharma company to release figures suggesting 2013 was more of a struggle than it would like, …
INC Research appoints Pfizer head
February 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing INC Research, Pfizer, setnik
Clinical research organisation INC Research has hired Dr Beatrice Setnik from Pfizer to be its vice president of Clinical Pharmacology. …
Cancer awareness campaign slated
February 7, 2014Medical Communications, Sales and Marketing Cancer, adverts, pancreatic, research uk, testicular
An ad campaign by Pancreatic Cancer Action has drawn criticism from other charities for ‘pitting’ different types of cancer against …
Celgene ‘downplayed’ Thalomid, Revlimid risks
February 7, 2014Medical Communications, Sales and Marketing Celgene, Revlimid, Thalidomide, thalomid
A former sales representative for US pharma firm Celgene is accusing her old company of promoting two of its key …
GCI Health expands with three hires
February 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bath, GCI Health, Red Door, starr, woods
Healthcare comms agency GCI Health has grown its London-based team by hiring senior account director Claire Woods, account director Laura …
AstraZeneca battling ‘headwinds’
February 7, 2014Sales and Marketing AstraZeneca, Soriot, farxiga, q4, results, xigduo
AstraZeneca is to shed another 550 jobs as its latest corporate restructure takes shape, bringing to 5,600 the number of …
Six Code breaches for HRA Pharma
February 6, 2014Medical Communications, Sales and Marketing ABPI, HRA Pharma, PMCPA, code, ella one
HRA Pharma has been slammed by the PMCPA after breaching six clauses of the ABPI Code of Practice in its …
Analysts ‘disappointed’ by Sanofi guidance
February 6, 2014Sales and Marketing Aubagio, Plavix, Sanofi, q4, sales
Sanofi has announced a mixed bag for its full year results as analysts have questioned why its forecasts for the …
Gilead to allow cheaper generics of new hep C drug
February 6, 2014Manufacturing and Production, Sales and Marketing Gilead, India, generics, hep C, s&m, sofosbuvir, sovaldi
Gilead has announced the unusual step of allowing its new and highly expensive hepatitis C pill to be sold as …
Nicox makes two appointments
February 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NicOx, nguyen, nicolas
French pharma firm Nicox has hired Evelyne Nguyen to be its chief financial officer and Stéphane Nicolas joins its executive …
GSK to make ‘fundamental changes’
February 6, 2014Sales and Marketing China, GSK, Tafinlar, Witty, q4, results
GlaxoSmithKline has pledged to make ‘fundamental changes’ to the manner in which it does business, looking at its interaction with …
Globe faces cancer ‘tidal wave’
February 5, 2014Research and Development, Sales and Marketing Cancer, WHO, globe, world cancer report
The World Health Organisation has warned of a ‘tidal wave’ of cancer cases which it says will sweep across the …
Drug giants team up for Alzheimer’s
February 5, 2014Research and Development, Sales and Marketing Accelerating Medicines Partnership, Alzheimer's, Alzheimer’s, GSK, Merck, National Institutes of Health, Pfizer
The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …
Laird chief executive takes up key innovation role




February 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing david lockwood, laird
David Lockwood OBE has been appointed to an influential business innovation role in the UK as non-executive chair of the …
Three new entries to Cancer Drugs Fund
February 5, 2014Research and Development, Sales and Marketing CDF, Kadcyla, NHS, Tafinlar, UK, xofigo
Three drugs – Roche’s Kadcyla, Bayer’s Xofigo and GlaxoSmithKline’s Tafinlar – have been added to England’s Cancer Drugs Fund (CDF). …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
